An empirical process for the design of high-throughput screening deck filters

Journal of Chemical Information and Modeling

Volumn 46, Issue 3, 2006, Pages 1060-1068

  Pearce, Bradley C ^a,b   Sofia, Michael J ^a,b   Good, Andrew C ^a,c   Drexler, Dieter M ^a,d   Stock, David A ^a,e  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b Applied Biotechnologies   (United States)

^c Pharmaceutical Candidate Optimization ^*

^d Discovery Analytical Sciences   (United States)

^e Non Clinical Biostatistics

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; CORRELATION METHODS; DATA ACQUISITION; MAPPING; SCREENING; STATISTICAL METHODS;

HIGH-THROUGHPUT SCREENING (HTS); HIGH-THROUGHPUT SCREENING DECK FILTERS; HIT MULTIPLE ASSAYS;

THROUGHPUT;

ARTICLE; DRUG DESIGN; DRUG INDUSTRY; EMPIRICAL RESEARCH;

DRUG DESIGN; DRUG INDUSTRY; EMPIRICAL RESEARCH;

EID: 33745381593     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050504m     Document Type: Article

References (47)

1. Walters, W. P.; Namchuk, M. A guide to drug discovery: Designing screens: how to make your hits a hit. Nat. Rev. Drug Discovery 2003, 2 (4), 259-266.
2. Rishton, G. M. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discovery Today 2002, 8 (2), 86-96.
3. Glick, M.; Klon, A. E.; Acklin, P.; Davies, J. W. Enrichment of extremely noisy high-throughput screening data using a naive Bayes classifier. J. Biomol. Screening 2004, 9 (1), 32-36.
4. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23 (1-3), 3-25.
5. Blower, P. E., Jr.; Cross, K. P.; Fligner, M. A.; Myatt, G. J.; Verducci, J. S.; Yang, C. Systematic analysis of large screening sets in drug discovery. Curr. Drug Discovery Technol. 2004, I (1), 37-47.
6. Baurin, N.; Baker, R.; Richardson, C.; Chen, I.; Foloppe, N.; Potter, A.; Jordan, A.; Roughley, S.; Parratt, M.; Greaney, P.; Morley, D.; Hubbard, R. E. Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totaling 2.7 Million Compounds. J. Chem. Inf. Comput. Sci. 2004, 44 (2), 643-651.
7. Walters, W. P.; Murcko, M. A. Prediction of 'drug-likeness'. Adv. Drug Delivery Rev. 2002, 54 (3), 255-271.
8. Hann, M.; Hudson, B.; Lewell, X.; Lifely, R.; Miller, L.; Ramsden, N. Strategic Pooling of Compounds for High-Throughput Screening. J. Chem. Inf. Comput. Sci. 1999, 39 (5), 897-902.
9. Lajiness, M. S.; Maggiora, G. M.; Shanmugasundaram, V. Assessment of the Consistency of Medicinal Chemists in Reviewing Sets of Compounds. J. Med. Chem. 2004, 47 (20), 4891-4896.
10. Presented in part, at the 229th American Chemical Society National Meeting, San Diego, CA, March 2005; CINF-085.
11. Wenlock, M. C.; Austin, R. P.; Barton, P.; Davis, A. M.; Leeson, P. D. A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs. J. Med. Chem. 2003, 46 (7), 1250-1256.
12. Daylight Chemical Information Systems; Mission Viejo Inc.: CA. http://www.daylight.com.
13. Pipeline Pilot Version 4.5.1.0; Scitegic: San Diego, CA. http://www.scitegic.com.
14. Perl Version 5.8.1; http://www.perl.com.
15. JMP Version 5.0.1a; SAS: Cary, NC. http://www.jmp.com.
16. Meyer, P. Introductory Probability and Statistical Applications; Addison-Wesley Publishing Company: Reading, MA, 1970.
17. Urdan, T. C. Statistics in Plain English; Lawrence Erlbaum Association: London, 2001.
18. Compounds are individually submitted to the LC-UV/MS based structural integrity (SI) assay as samples of 10 μL, 3 mM solutions in DMSO formatted in shallow 96-well-plates. The samples are diluted and mixed 1:14 with 130 μL of a solvent cocktail of 2-propanol/water/acetonitrile (33%:33%:33%, v:v:v) utilizing a TECAN liquid handler. The solvent mixture is used to ensure solubility of the compounds in LC and MS compatible solvents. The samples are then analyzed by rapid gradient in-line LC - UV/MS utilizing UV detection at 220 nm, and ion-trap mass spectrometers employing positive-negative-switching with data-dependent full scan MS/MS methods in electrospray ionization mode (ESI), and if necessary, also in atmospheric pressure chemical ionization mode (APCI). The acquired SI data are automatically processed by "intelligent" in-house software developed in Visual Basic and ThermoElectron Finnigan Xcalibur Developers Toolkit (XDK).
19. Josephs, J. L.; Sanders, M.; Langish, R. A.; Hnatyshyn, S. Y.; Salyan, M. E.; Shipkova, P.; Drexler, D.; Flynn, M. J.; Burdette, H. L.; Balimane, P.; Zvyaga, T. A.; Chong, S. In High Quality High Throughput LC/MS Strategy for Profiling of Drug Candidates with Applications to Structural Integrity, Permeability, Stability, and Related Assays; Proceedings of the 50th ASMS Conference, Orlando, Florida, June 02-06, 2002, A021460.pdf, 2002; 2002.
20. Roche, O.; Schneider, P.; Zuegge, J.; Guba, W.; Kansy, M.; Alanine, A.; Bleicher, K.; Danel, F.; Gutknecht, E.-M.; Rogers-Evans, M.; Neidhart, W.; Stalder, H.; Dillon, M.; Sjoegren, E.; Fotouhi, N.; Gillespie, P.; Goodnow, R.; Harris, W.; Jones, P.; Taniguchi, M.; Tsujii, S.; von Saal, W.; Zimmermann, G.; Schneider, G. Development of a Virtual Screening Method for Identification of "Frequent Hitters" in Compound Libraries. J. Med. Chem. 2002, 45 (1), 137-142.
21. McGovern, S. L.; Caselli, E.; Grigorieff, N.; Shoichet, B. K. A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening. J. Med. Chem. 2002, 45 (8). 1712-1722.
22. McGovern, S. L.; Helfand, B. T.; Feng, B.; Shoichet, B. K. A Specific Mechanism of Nonspecific Inhibition. J. Med. Chem. 2003, 46 (20). 4265-4272.
23. Seidler, J.; McGovern, S. L.; Doman. T. N.; Shoichet, B. K. Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs. J. Med. Chem. 2003, 46 (21), 4477-4486.
24. Doman, T. N.; Shoichet. B. K. In Identification and Prediction of Self-Aggregating Compounds in Drug Discovery Settings; Abstracts, 36th Central Regional Meeting of the American Chemical Society, Indianapolis, IN, United States, June 2-4, 2004; 2004; pp INV-025.
25. Leadscope Inc.: Columbus, OH. http://www.leadscope.com.
26. Diller, D. J.: Hobbs, D. W. Deriving Knowledge through Data Mining High-Throughput Screening Data. J Med. Chem. 2004, 47(25), 6373-6383.
27. Hann, M. M.; Leach, A. R.; Harper, G. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery. J. Chem. Inf. Comput. Sci. 2001, 41 (3), 856-864.
28. Herklots, H. Outsourcing the search for leads. Modern Drug Discovery March, 2000; pp 48-50.
29. COMDECOM information: http://www.specs.net.
30. Kozikowski, B. A.; Burt, T. M.; Tirey, D. A.; Williams, L. E.; Kuzmak, B. R.; Stanton, D. T.; Morand, K. L.; Nelson, S. L. The effect of freeze/thaw cycles on the stability of compounds in DMSO. J. Biomol. Screening 2003, 8 (2), 210-215.
31. Kozikowski, B. A.; Burt, T. M.; Tirey, D. A.; Williams, L. E.; Kuzmak, B. R.; Stanton, D. T.; Morand, K. L.; Nelson, S. L. The effect of room-temperature storage on the stability of compounds in DMSO. J. Biomol. Screening 2003, 8 (2), 205-209.
32. Cheng, X.; Hochlowski, J.; Tang, H.; Hepp, D.; Beckner, C.; Kantor, S.; Schmitt, R. Studies on repository compound stability in DMSO under various conditions. J. Biomol. Screening 2003, 8 (3), 292-304.
33. Buko, A. M.; Beckner, C.; Hepp, D.; Helias, N.; Zhu, F.; Nemcek, T.; Schmitt, R. J.; Hochlowski, J. In Stability testing of chemical diversity in liquid DMSO storage; Abstracts of Papers, 222nd ACS National Meeting, Chicago, IL, United States, August 26-30, 2001, 2001; pp ANYL-210.
34. Zhong, J.; Groutas, W. C. Recent developments in the design of mechanism-based and alternate substrate inhibitors of serine proteases. Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2004, 4(12), 1203-1216.
35. Sanderson, P. E. J. Small, noncovalent serine protease inhibitors. Med. Res. Rev. 1999, 19(2), 179-197.
36. Ilies, M. A.; Scozzafava, A.; Supuran, C. T. Therapeutic applications of serine protease inhibitors. Expert Opin. Ther. Pat. 2002, 12 (8), 1181-1214.
37. Mehdi, S. Synthetic and naturally occurring protease inhibitors containing an electrophilic carbonyl group. Bioorg. Chem. 1993, 21 (3), 349-59.
38. Lin, C.; Lin, K.; Luong, Y.-P.; Rao, B. G.; Wei, Y.-Y.; Brennan, D. L.; Fulghum, J. R.; Hsiao, H.-M.; Ma, S.; Maxwell, J. P.; Cottrell, K. M.; Perni, R. B.; Gates, C. A.; Kwong, A. D. In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms. J. Biol. Chem. 2004, 279 (17), 17508-17514.
39. Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39 (15), 2887-2893.
40. Vieth, M.; Siegel, M. G.; Higgs, R. E.; Watson, I. A.; Robertson, D. H.; Savin, K. A.; Durst, G. L.; Hipskind, P. A. Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs. J. Med. Chem. 2004, 47 (1), 224-232.
41. Hajduk, P. J.; Bures, M.; Praestgaard, J.; Fesik, S. W. Privileged molecules for protein binding identified from NMR-based screening. J. Med. Chem. 2000, 43 (18), 3443-3447.
42. Gillet, V. J.; Willett, P.; Bradshaw, J. Identification Of Biological Activity Profiles Using Substructural Analysis And Genetic Algorithms. J. Chem. Inf. Comput. Sci. 1998, 38 (2), 165-179.
43. Schnur, D.; Hermsmeier, M. A. In Classpharmer and the quest for privileged substructures; Abstracts of Papers, 228th ACS National Meeting, Philadelphia, PA, United States, August 22-26, 2004, 2004; pp CINF-080.
44. Hermsmeier, M. A.; Schnur, D.; Pearce, B. C. In Systematic bioactivity classification of ligands onto a protein target ontology: Application for library design and virtual profiling of a compound collection; Abstracts of Papers, 227th ACS National Meeting, Anaheim, CA, United States, March 28-April 1, 2004, 2004; pp CINF-014.
45. Charifson, P. S.; Walters, W. P. Filtering databases and chemical libraries. Mol. Diversity 2002, 5 (4), 185-197.
46. Lajiness, M. S.; Shanmugasundaram, V. Strategies for the identification and generation of informative compound sets. Methods Mol. Biol. (Totowa, NJ, United States) 2004, 275 (Chemoinformatics), 111-129.
47. Martin, Y. C.; Kofron, J. L.; Traphagen, L. M. Do Structurally Similar Molecules Have Similar Biological Activity? J. Med. Chem. 2002, 45 (19), 4350-4358.